This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Glaxo Group Limited, Glaxogrouplimited. Active years: 2005-2010.
Location History:
- Buntingford, GB (2005)
- Stevenage, GB (2010)
Company Filing History:
Years Active: 2005-2010
Title: Michael Robert West: Innovator in Immunology and Respiratory Health
Introduction
Michael Robert West is a notable inventor based in Stevenage, GB. He has made significant contributions to the fields of immunology and respiratory health, holding a total of 2 patents. His work focuses on innovative methods and compositions that address critical health issues.
Latest Patents
West's latest patents include groundbreaking inventions in the realm of immunoglobulins and chronic obstructive pulmonary disease (COPD). The first patent concerns immunoglobulins, specifically antibodies that bind to Oncostatin M (OSM) and modulate its interaction with gp130. This invention also includes antibodies that affect the interaction between Site II and Site III of OSM and their respective partners. Additionally, it encompasses pharmaceutical compositions, screening methods, and medical treatment approaches. The second patent addresses methods for determining the severity of COPD in patients by measuring the concentration of soluble E-cadherin in urine and blood serum. This invention provides a method for treating COPD patients and includes a prognostic product for detecting sE-cadherin levels.
Career Highlights
Throughout his career, Michael Robert West has worked with prominent companies, including Glaxo Group Limited. His experience in these organizations has contributed to his expertise in developing innovative health solutions.
Collaborations
West has collaborated with notable individuals in his field, including Jonathan Henry Ellis and Christopher Plumpton. These partnerships have likely enhanced his research and development efforts.
Conclusion
Michael Robert West is a distinguished inventor whose work in immunology and respiratory health has led to significant advancements. His patents reflect a commitment to improving patient care and treatment methodologies.